Desq Long
Sign in
SEC FORM 4
$3,741,148.53

REGENERON PHARMACEUTICALS, INC. (REGN)

Disposition (code F) of 4,599 shares at $813.47 per share.

Reporting Person Fenimore Christopher R. · Officer Title EVP Finance CFO · Transaction Code F

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001697422-26-000002 · filed 2026-08-20 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "REGENERON PHARMACEUTICALS, INC. (REGN)." Disclosed 2026-08-20. https://desqlong.com/cards/0001697422-26-000002-2 (retrieved 2026-09-26).